| Year |
Citation |
Score |
| 2014 |
Gardinier J, Yang W, Madden GR, Kronbergs A, Gangadharan V, Adams E, Czymmek K, Duncan RL. P2Y2 receptors regulate osteoblast mechanosensitivity during fluid flow. American Journal of Physiology. Cell Physiology. 306: C1058-67. PMID 24696143 DOI: 10.1152/Ajpcell.00254.2013 |
0.37 |
|
| 2013 |
Srinivasan P, Kronbergs A, Duncan R, Kirn-Safran C. Bone mechanotransduction via T-type voltage sensitive calcium channel plays a key role in induction of the osteoarthritic phenotype Osteoarthritis and Cartilage. 21: S232. DOI: 10.1016/J.Joca.2013.02.478 |
0.378 |
|
| 2009 |
Fomin VP, Kronbergs A, Gunst S, Tang D, Simirskii V, Hoffman M, Duncan RL. Role of protein kinase Calpha in regulation of [Ca2+](I) and force in human myometrium. Reproductive Sciences (Thousand Oaks, Calif.). 16: 71-9. PMID 19087983 DOI: 10.1177/1933719108324892 |
0.501 |
|
| 2006 |
Fomin V, Kronbergs A, Hoffman M. Protein kinase C (PKC) regulates contractility of myometrium from pregnant women American Journal of Obstetrics and Gynecology. 195: S53. DOI: 10.1016/J.Ajog.2006.10.155 |
0.503 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Deodhar A, Mease P, Rahman P, Navarro-Compán V, Marzo-Ortega H, Hunter T, Sandoval D, Kronbergs A, Leon L, Shan M, Leung A, De Vlam K, Strand V. Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial. Rheumatology and Therapy. PMID 33284423 DOI: 10.1007/s40744-020-00254-z |
0.125 |
|
| 2021 |
Combe B, Tsai TF, Huffstutter JE, Sprabery AT, Lin CY, Park SY, Kronbergs A, Hufford MM, Nash P. Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies. Arthritis Research & Therapy. 23: 41. PMID 33499913 DOI: 10.1186/s13075-020-02388-5 |
0.107 |
|
| 2011 |
Kronbergs A, Kronbergs E, Siraks E, Adamovics A. Cutting properties of different hemp varieties in dependence on the cutter mechanism Engineering For Rural Development. 446-451. |
0.099 |
|
| 2022 |
Coates LC, Mease P, Kronbergs A, Helt C, Sandoval D, Park SY, Combe B, Nash P, Deodhar A. Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results. Clinical Rheumatology. PMID 35674861 DOI: 10.1007/s10067-022-06218-8 |
0.091 |
|
| 2022 |
Coates LC, Mease P, Kronbergs A, Helt C, Sandoval D, Park SY, Combe B, Nash P, Deodhar A. Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results. Clinical Rheumatology. PMID 35821169 DOI: 10.1007/s10067-022-06271-3 |
0.087 |
|
| 2021 |
van der Heijde D, Østergaard M, Reveille JD, Baraliakos X, Kronbergs A, Sandoval DM, Li X, Carlier H, Adams DH, Maksymowych WP. Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years. The Journal of Rheumatology. PMID 34853086 DOI: 10.3899/jrheum.210471 |
0.082 |
|
| 2021 |
Deodhar A, Mease P, Marzo-Ortega H, Hunter T, Sandoval D, Kronbergs A, Lauzon S, Leung A, Navarro-Compán V. Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks. Bmc Rheumatology. 5: 50. PMID 34560906 DOI: 10.1186/s41927-021-00218-y |
0.072 |
|
| 2013 |
Kronbergs A, Kronbergs E, Repsa E, Smits M. Bale shredder efficiency dependence on settings Engineering For Rural Development. 477-481. |
0.068 |
|
| 2013 |
Repsa E, Kronbergs E, Kronbergs A. Evaluation of biomass briquetting mechanism Vide. Tehnologija. Resursi - Environment, Technology, Resources. 1: 186-189. |
0.057 |
|
| 2010 |
Kronbergs A, Kronbergs E, Smits M, Siraks E. Investigation of comon reed cutting methods Conference Proceeding - 4th International Conference, Tae 2010: Trends in Agricultural Engineering 2010. 338-342. |
0.054 |
|
| 2013 |
Kronbergs A, Kronbergs E, Repsa E. Evaluation of reed canary grass shredding and compacting properties Agronomy Research. 11: 61-66. |
0.053 |
|
| 2012 |
Kronbergs A, Kronbergs E, Rozinskis R. Size reduction of common reeds for biofuel production Engineering For Rural Development. 11: 257-261. |
0.049 |
|
| 2011 |
Kronbergs A, Širaks E, Adamovičs A, Kronbergs E. Mechanical properties of hemp (Cannabis sativa) biomass Vide. Tehnologija. Resursi - Environment, Technology, Resources. 1: 184-190. |
0.046 |
|
| 2024 |
Deodhar A, Blauvelt A, Lebwohl M, Feely M, Kronbergs A, Eberhart N, Zhu D, Inman E, Grace E, Holzkaemper T, Rahman P, Marzo-Ortega H, Papp KA, Merola JF, Gottlieb AB, et al. Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials. Arthritis Research & Therapy. 26: 49. PMID 38347650 DOI: 10.1186/s13075-023-03257-7 |
0.041 |
|
| 2021 |
Genovese MC, Mysler E, Tomita T, Papp KA, Salvarani C, Schwartzman S, Gallo G, Patel H, Lisse JR, Kronbergs A, Leage SL, Adams DH, Xu W, Marzo-Ortega H, Lebwohl MG. Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials. Rheumatology (Oxford, England). PMID 34549772 DOI: 10.1093/rheumatology/keab566 |
0.035 |
|
| 2020 |
Genovese MC, Mysler E, Tomita T, Papp KA, Salvarani C, Schwartzman S, Gallo G, Patel H, Lisse JR, Kronbergs A, Leage SL, Adams DH, Xu W, Marzo-Ortega H, Lebwohl MG. Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials. Rheumatology (Oxford, England). PMID 32449924 DOI: 10.1093/rheumatology/keaa189 |
0.035 |
|
| 2023 |
Deodhar A, Poddubnyy D, Rahman P, Ermann J, Tomita T, Bolce R, Leage SL, Kronbergs A, Johnson C, Araújo J, Leung A, van der Heijde D. Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program. The Journal of Rheumatology. 50: 718. PMID 37127315 DOI: 10.3899/jrheum.221022.C1 |
0.033 |
|
| 2023 |
Deodhar A, Poddubnyy D, Rahman P, Ermann J, Tomita T, Bolce R, Leage SL, Kronbergs A, Johnson C, Araújo J, Leung A, van der Heijde D. Long-term safety and efficacy of ixekizumab in patients with axial spondyloarthritis: 3-year data from the COAST program. The Journal of Rheumatology. PMID 36792107 DOI: 10.3899/jrheum.221022 |
0.024 |
|
| Hide low-probability matches. |